Bioventix PLC (BVXP) Insider Ian James Nicholson Sells 2,500 Shares
Bioventix PLC (LON:BVXP) insider Ian James Nicholson sold 2,500 shares of Bioventix PLC stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of GBX 2,401 ($31.90), for a total value of £60,025 ($79,756.84).
Bioventix PLC (LON:BVXP) opened at 2433.00 on Friday. The firm’s 50 day moving average price is GBX 2,607.64 and its 200-day moving average price is GBX 2,087.02. The stock’s market cap is GBX 123.43 million. Bioventix PLC has a 1-year low of GBX 1,250.00 and a 1-year high of GBX 2,950.00.
The firm also recently announced a dividend, which will be paid on Friday, November 10th. Stockholders of record on Thursday, October 26th will be issued a GBX 71 ($0.94) dividend. This represents a dividend yield of 2.67%. This is a boost from Bioventix PLC’s previous dividend of $20.00. The ex-dividend date of this dividend is Thursday, October 26th.
TRADEMARK VIOLATION NOTICE: “Bioventix PLC (BVXP) Insider Ian James Nicholson Sells 2,500 Shares” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/20/bioventix-plc-bvxp-insider-ian-james-nicholson-sells-2500-shares.html.
Separately, FinnCap reiterated a “corporate” rating and set a GBX 2,600 ($34.55) price objective on shares of Bioventix PLC in a research note on Monday.
Bioventix PLC Company Profile
Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.
Receive News & Ratings for Bioventix PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix PLC and related companies with MarketBeat.com's FREE daily email newsletter.